| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2850112 | American Heart Journal | 2013 | 14 Pages |
Abstract
In a large systematic overview of comparative trials involving percutaneous revascularization with drug-eluting stents, treatment with EES significantly reduced the risk of repeat revascularization and definite ST compared to SES. We found no significant differences in the risk of cardiac death or myocardial infarction.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kyung Woo MD, PhD, Si-Hyuck MD, Matthijs A. MD, Dong-Ho MD, Seokyung PhD, Woo-Hyun MD, Han-Mo MD, PhD, Hae-Young MD, PhD, Adrianus J. MD, PhD, Sjoerd H. MD, PhD, Hyun-Jae MD, PhD, Bon-Kwon MD, PhD, Byung-Hee MD, PhD, Young-Bae MD, PhD, David E. MD,